A Prospective, Randomized, Interventional Study of Oral Iron Supplementation Comparing Daily Dose with Alternate Day Regimen Using Hepcidin as a Biomarker in Iron Deficiency Anemia.

Abstract

AIM: To assess effect of daily vis-a-vis alternate day oral iron therapy in terms of hemoglobin, reticulocyte hemoglobin equivalent (RET-He) and GI side effects using hepcidin as a biomarker. METHODS: A hospital based randomized interventional two-arm analytical study was done among patients of IDA (20 in each group). The study population was divided into two groups by randomisation. Group 1 received oral iron supplements on alternate day and …

Authors

Mehta S; Sharma BS; Gulati S; Sharma N; Goyal LK; Mehta S

Journal

Journal of Association of Physicians of India, Vol. 68, No. 5, pp. 39–41

Publication Date

May 2020

ISSN

0004-5772

Associated Experts

Shamir Mehta

Professor, Faculty of Health Sciences

Visit profile

Labels

Fields of Research (FoR)

32 Biomedical and Clinical Sciences 3202 Clinical Sciences

Medical Subject Headings (MeSH)

Anemia, Iron-Deficiency Biomarkers Dietary Supplements Hemoglobins Hepcidins Humans Iron Prospective Studies